Loading…
Medtronic plc is projected to rise to $95.78 by 2027, a +14% move from its current price of $84.22. MDT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $82.93 | $84.25 | $85.60 | +0.04% |
| Jul 30 | $82.42 | $84.29 | $86.20 | +0.08% |
| Jul 31 | $82.03 | $84.32 | $86.67 | +0.12% |
| Aug 1 | $81.72 | $84.36 | $87.08 | +0.16% |
| Aug 2 | $81.44 | $84.39 | $87.44 | +0.20% |
| Aug 3 | $81.20 | $84.42 | $87.77 | +0.24% |
| Aug 4 | $80.98 | $84.46 | $88.08 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $80.98 | $84.46 | $88.08 | +0.28% |
| Week 2 | $79.81 | $84.70 | $89.88 | +0.56% |
| Week 3 | $78.97 | $84.93 | $91.35 | +0.85% |
| Week 4 | $78.31 | $85.17 | $92.64 | +1.13% |
| Week 5 | $77.75 | $85.41 | $93.83 | +1.42% |
| Week 6 | $77.27 | $85.65 | $94.94 | +1.70% |
| Week 7 | $76.85 | $85.89 | $96.00 | +1.99% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medtronic plc is a healthcare company that develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio. The Cardiovascular Portfolio offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, ECMO systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as the Accurian nerve ablation system. The Medical Surgical Portfolio offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors.
Medtronic was founded in 1949 and is headquartered in Galway, Ireland.
Medtronic plc (MDT) is a healthcare device maker with a current price of $82.01, a market capitalization of $104.98B, and a ranking of 143. The near-term technical picture is neutral, with a 30-day range from $74.09 to $90.77 and key levels at $78.14 (support) and $83.87 (resistance). The moving averages sit at $79.79 (SMA50) and $90.46 (SMA200).
The forecast implies a rising long-term trajectory, with the 2026 average at $82.01, the 2029 average at $107.36, and the 2030 average at $117.16. Longer-term outlooks place the average at $266.14 for 2040 and $556.44 for 2050, signaling a bullish trend through the horizon.
A major floor 12.4% below — a decisive break under it would weaken the trend.
The nearest floor, 7.2% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 5.3% above — clearing it would confirm fresh momentum.
Key MDT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $82.75 | Buy | $82.91 | Buy |
| MA 10 | $82.39 | Buy | $82.59 | Buy |
| MA 20 | $82.08 | Buy | $82.03 | Buy |
| MA 50 | $79.94 | Buy | $81.61 | Buy |
| MA 100 | $82.70 | Buy | $83.72 | Buy |
| MA 200 | $90.38 | Sell | $86.80 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.07 | Neutral |
| Stoch RSI (14) | 78.44 | Neutral |
| CCI (20) | 104.43 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 2.69 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 1.39 | Buy |
| Ultimate (7,14,28) | 66.54 | Neutral |
| Momentum (10) | 0.35 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 82.65 | Buy |
| ADX (14) | 11.61 | Neutral |
| ATR (14) | 1.20 | Info |
The 30-day technical picture shows a neutral stance, with RSI(14) at 50. The SMA50 is $79.79 and the SMA200 is $90.46, indicating near-term support near the lower edge of the recent range and resistance near the $83.87 level. The 30-day range spans from $74.09 to $90.77, highlighting the price variance within the month.
A close watch on $78.14 as support and $83.87 as resistance can help frame near-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $73.75 | $84.22 | $110.33 | 0% | Neutral | |
| $78.52 | $95.78 | $122.10 | +14% | Neutral | |
| $79.98 | $99.42 | $130.21 | +18% | Neutral | |
| $87.99 | $111.07 | $148.60 | +32% | Bullish | |
| $95.26 | $121.89 | $166.02 | +45% | Bullish | |
| $113.78 | $147.37 | $203.92 | +75% | Bullish | |
| $125.73 | $164.68 | $231.13 | +96% | Bullish | |
| $124.67 | $165.02 | $234.62 | +96% | Bullish | |
| $133.25 | $178.13 | $256.30 | +112% | Bullish | |
| $140.43 | $189.52 | $275.73 | +125% | Bullish | |
| $198.49 | $279.41 | $426.05 | +232% | Bullish | |
| $389.11 | $587.48 | $960.33 | +598% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $73.75 | $84.22 | $98.60 | +0.00% |
| August 2026 | $73.86 | $86.18 | $102.52 | +2.33% |
| September 2026 | $74.46 | $87.36 | $104.87 | +1.37% |
| October 2026 | $73.42 | $86.53 | $104.63 | -0.95% |
| November 2026 | $73.92 | $87.44 | $106.36 | +1.05% |
| December 2026 | $76.01 | $90.22 | $110.33 | +3.18% |
Click any year to see its month-by-month MDT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MDT price prediction for 2026 points to an average of $84.22 (low $73.75, high $110.33) — a potential gain of 0% on today's $84.22. Price action looks broadly range-bound.
In 2027, MDT is projected to trade between $78.52 and $122.10, averaging $95.78 — a potential gain of +14% from today's $84.22. That is up +14% on the projected 2026 average. A consolidation phase looks the most probable path here.
Medtronic plc's 2028 outlook centres on $99.42, within a $79.98 to $130.21 range. That is up +4% on the projected 2027 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2029, MDT could reach as high as $148.60, with a base case around $111.07 and support toward $87.99 — roughly +32% from $84.22. Buyers look set to stay in control over this stretch.
Expect MDT to range from $95.26 to $166.02 through 2030. The $121.89 average target implies a +45% move from current prices. That is up +10% on the projected 2029 average. Momentum favours further upside here.
The MDT price prediction for 2031 points to an average of $147.37 (low $113.78, high $203.92) — a potential gain of +75% on today's $84.22. Buyers look set to stay in control over this stretch.
In 2032, MDT is projected to trade between $125.73 and $231.13, averaging $164.68 — a potential gain of +96% from today's $84.22. That is up +12% on the projected 2031 average. Momentum favours further upside here.
Medtronic plc's 2033 outlook centres on $165.02, within a $124.67 to $234.62 range. That is up 0% on the projected 2032 average. That marks a +96% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MDT could reach as high as $256.30, with a base case around $178.13 and support toward $133.25 — roughly +112% from $84.22. Momentum favours further upside here.
Expect MDT to range from $140.43 to $275.73 through 2035. The $189.52 average target implies a +125% move from current prices. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MDT price prediction for 2040 points to an average of $279.41 (low $198.49, high $426.05) — a potential gain of +232% on today's $84.22. Momentum favours further upside here.
In 2050, MDT is projected to trade between $389.11 and $960.33, averaging $587.48 — a potential gain of +598% from today's $84.22. That is up +110% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MDT today (≈ 11.873664 MDT) could be worth
$6,975.6
+$5,975.6 (+598%) by 2050 · US Dollar
Based on the average projected MDT price of $587.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDTwould be worth at today's price.
$1,000 invested in MDT on Jul 28, 2025 (≈ 10.873111 MDT) would be worth
$915.73
-$84.27 (-8.4%) today · 0.92× · US Dollar
Based on a MDT entry price of $91.97 vs. today's $84.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $83.29 | $1,011.17 | +1.1% |
| 1 month ago | $80.98 | $1,040.01 | +4.0% |
| 3 months ago | $81.9 | $1,028.33 | +2.8% |
| 6 months ago | $100.79 | $835.6 | -16.4% |
| 1 year ago | $91.97 | $915.73 | -8.4% |
| All time (5.0y) ago | $130.68 | $644.48 | -35.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDT forecast.
Our base-case forecast reaches $170.00 around 2034.
Implied market cap at $170.00: $217.61B
The multi-year forecast paints a bullish path, with growing upside across the horizon. The 2030 average is $117.16 with a min of $91.56, a max of $159.62, and a 42.9% ROI, signaling a solid long-run appreciation. By 2040, the average rises to $266.14 (min $189.05, max $405.85) and a 224.5% ROI, followed by 2050 with an average of $556.44 (min $368.53, max $909.64) and a 578.5% ROI.
The sentiment is listed as BULLISH for 2029 onward and remains bullish through 2050, reflecting a strong long-term appreciation potential alongside broader sector dynamics. These are estimates and not guarantees, and actual results can differ.
Tap a question to reveal the answer.
2030 average price is $117.16, with a min of $91.56 and a max of $159.62. The forecast also shows a 42.9% ROI and a bullish sentiment.
Forecasts show ROIs of 13.1% in 2027, 17.4% in 2028, 30.9% in 2029, 42.9% in 2030, 72.9% in 2031, 92.8% in 2032, 92.2% in 2033, 108.3% in 2034, 121.1% in 2035, 224.5% in 2040, and 578.5% in 2050, with sentiment turning BULLISH from 2029 onward.
Yes. The 2030 max is $159.62, which would exceed $150, while the 2030 average is $117.16.
Current price is $82.01 and market cap is $104.98B, with a ranking of 143.
For 2040, the forecasted average is $266.14 (min $189.05, max $405.85) with a 224.5% ROI and bullish sentiment. For 2050, the forecasted average is $556.44 (min $368.53, max $909.64) with a 578.5% ROI and bullish sentiment.
Medtronic plc Community Discussion
0Share your Medtronic plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.